Managing HIV disease after Delta.
作者信息
Pinching A J
出版信息
BMJ. 1996 Mar 2;312(7030):521-2. doi: 10.1136/bmj.312.7030.521.
Abstract
摘要
相似文献
1
Managing HIV disease after Delta.德尔塔变异株出现后的艾滋病管理
BMJ. 1996 Mar 2;312(7030):521-2. doi: 10.1136/bmj.312.7030.521.
2
Therapy for human immunodeficiency virus infection -- what have we learned?人类免疫缺陷病毒感染的治疗——我们学到了什么？
N Engl J Med. 1996 Oct 10;335(15):1142-4. doi: 10.1056/NEJM199610103351509.
3
Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction.HIV感染的治疗：抗逆转录病毒核苷类似物。引言。
Hosp Pract (Off Ed). 1992 Aug;27 Suppl 2:3-4. doi: 10.1080/21548331.1992.11705594.
4
New developments in antiretroviral drug therapy for HIV infection.用于治疗HIV感染的抗逆转录病毒药物疗法的新进展。
AIDS Clin Rev. 1992:69-104.
5
Combination superior to zidovudine in Delta trial.在Delta试验中，联合用药优于齐多夫定。
Lancet. 1995 Sep 30;346(8979):895. doi: 10.1016/s0140-6736(95)92725-5.
6
The Delta trial.德尔塔试验。
Lancet. 1997 Feb 1;349(9048):358-9. doi: 10.1016/S0140-6736(05)62860-7.
7
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.齐多夫定单独使用或与去羟肌苷或扎西他滨联合使用，用于患有获得性免疫缺陷综合征或每立方毫米CD4细胞少于200个的HIV感染患者。艾滋病临床研究特里·贝恩社区项目的研究人员。
N Engl J Med. 1996 Oct 10;335(15):1099-106. doi: 10.1056/NEJM199610103351503.
8
AZT combination trial shows positive results.
Nature. 1995 Sep 28;377(6547):277. doi: 10.1038/377277b0.
9
Study results at a glance.研究结果一览。
AIDS Alert. 1995 Nov;10(11):134.
10
Confirmation for combination AIDS therapy.
Science. 1995 Oct 6;270(5233):33.
引用本文的文献
1
The needs of children whose mothers have HIV infection.母亲感染艾滋病毒的儿童的需求。
Arch Dis Child. 1997 Dec;77(6):483-7. doi: 10.1136/adc.77.6.483.
2
Paediatric HIV infection.小儿HIV感染
Arch Dis Child. 1997 Apr;76(4):293-6. doi: 10.1136/adc.76.4.293.
3
Will we ever know when to treat HIV infection?
BMJ. 1996 Sep 7;313(7057):608-10. doi: 10.1136/bmj.313.7057.608.
4
Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection.沙奎那韦。关于其在治疗HIV感染中的药理学及临床应用潜力的综述。
Drugs. 1996 Jul;52(1):93-112. doi: 10.2165/00003495-199652010-00007.
5
Managing HIV disease without Delta.在没有德尔塔毒株的情况下管理艾滋病病毒疾病。
BMJ. 1996 Jun 15;312(7045):1542. doi: 10.1136/bmj.312.7045.1542b.
本文引用的文献
1
Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients.
JAMA. 1993 Dec 1;270(21):2583-9. doi: 10.1001/jama.270.21.2583.
2
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.叠氮胸苷（AZT）治疗艾滋病及艾滋病相关综合征患者的疗效。一项双盲、安慰剂对照试验。
N Engl J Med. 1987 Jul 23;317(4):185-91. doi: 10.1056/NEJM198707233170401.
3
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.齐多夫定（AZT）治疗轻度症状的1型人类免疫缺陷病毒（HIV）感染患者的安全性和有效性。一项双盲、安慰剂对照试验。艾滋病临床试验组。
Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727.
4
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.齐多夫定用于无症状人类免疫缺陷病毒感染。对每立方毫米CD4阳性细胞少于500个的患者进行的对照试验。美国国立过敏与传染病研究所艾滋病临床试验组。
N Engl J Med. 1990 Apr 5;322(14):941-9. doi: 10.1056/NEJM199004053221401.
Zotero 插件